Himmel Herbert M
BHC-GDD-GED-NDS-SP, Safety Pharmacology, Bayer HealthCare AG, Wuppertal, Germany.
Crit Rev Toxicol. 2008;38(9):773-803. doi: 10.1080/10408440802237664.
An increased sensitivity of the heart to catecholamines or cardiac sensitization is a recognized risk during acute human exposure to halogenated hydrocarbons used as solvents, foam-blowing or fire-extinguishing agents, refrigerants, and aerosol propellants. Although cardiac sensitization to such "industrial" halocarbons can result in serious arrhythmia and death, research into its mechanistic basis has been limited, whereas the literature on volatile anesthetics (e.g., halothane, chloroform) is comparably extensive. A review of the literature on halocarbons and related volatile anesthetics was conducted. The available experimental evidence suggests that volatile anesthetics at physiologically relevant concentrations interact predominantly with the main repolarizing cardiac potassium channels hERG and I(Ks), as well as with calcium and sodium channels at slightly higher concentrations. On the level of the heart, inhibition of these ion channels is prone to alter both action potential shape (triangulation) and electrical impulse conduction, which may facilitate arrhythmogenesis by volatile anesthetics per se and is potentiated by catecholamines. Action potential triangulation by regionally heterogeneous inhibition of calcium and potassium channels will facilitate catecholamine-induced afterdepolarizations, triggered activity, and enhanced automaticity. Inhibition of cardiac sodium channels will reduce conduction velocity and alter refractory period; this is potentiated by catecholamines and promotes reentry arrhythmias. Other cardiac and/or neuronal mechanisms might also contribute to arrhythmogenesis. The few scattered in vitro data available for halocarbons (e.g., FC-12, halon 1301, trichloroethylene) suggest inhibition of cardiac sodium (conduction), calcium and potassium channels (triangulation), extraneuronal catecholamine reuptake, and various neuronal ion channels. Therefore, it is hypothesized that halocarbons promote cardiac sensitization by similar mechanisms as volatile anesthetics. Experimental approaches for further investigation of these sensitization mechanisms by selected halocarbons are suggested.
心脏对儿茶酚胺的敏感性增加或心脏致敏是人类在急性接触用作溶剂、发泡剂、灭火剂、制冷剂和气溶胶推进剂的卤代烃期间公认的风险。尽管心脏对这类“工业”卤代烃的致敏作用可导致严重心律失常甚至死亡,但其作用机制的研究一直很有限,而关于挥发性麻醉剂(如氟烷、氯仿)的文献则相对较多。本文对卤代烃及相关挥发性麻醉剂的文献进行了综述。现有实验证据表明,生理相关浓度的挥发性麻醉剂主要与心脏主要复极化钾通道hERG和I(Ks)相互作用,浓度稍高时还与钙通道和钠通道相互作用。在心脏层面,这些离子通道的抑制易于改变动作电位形态(三角化)和电冲动传导,这可能会促进挥发性麻醉剂本身诱发心律失常,儿茶酚胺会增强这种作用。钙通道和钾通道的区域异质性抑制导致的动作电位三角化将促进儿茶酚胺诱导的后去极化、触发活动和自动节律增强。心脏钠通道的抑制会降低传导速度并改变不应期;儿茶酚胺会增强这种作用并促进折返性心律失常。其他心脏和/或神经机制也可能导致心律失常。关于卤代烃(如FC-12、哈龙1301、三氯乙烯)的少量体外数据表明,它们可抑制心脏钠通道(传导)、钙通道和钾通道(三角化)、神经外儿茶酚胺再摄取以及各种神经离子通道。因此,推测卤代烃通过与挥发性麻醉剂类似的机制促进心脏致敏。本文还提出了通过选定卤代烃进一步研究这些致敏机制的实验方法。